Back to Search
RICHARD CHAMPLIN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1366541054IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
H7397(TX)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1975
Research & Publications (20)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
PMID 17272503·Blood·2007
2-rct
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
PMID 12599934·Oncology (Williston Park)·2003
6-review
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.
PMID 16258420·Clin Adv Hematol Oncol·2003
8-other
Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.
PMID 11896552·Leukemia·2002
6-review
Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience.
PMID 11777103·Biol Blood Marrow Transplant·2001
8-other
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
PMID 11436116·Bone Marrow Transplant·2001
6-review
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
PMID 11122842·Curr Oncol Rep·2000
6-review
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
PMID 11091179·Br J Haematol·2000
6-review
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
PMID 19668237·Bone Marrow Transplant·2010
3-trial
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
PMID 19561648·Bone Marrow Transplant·2010
8-other
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
PMID 19539212·Biol Blood Marrow Transplant·2009
3-trial
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
PMID 19361747·Biol Blood Marrow Transplant·2009
8-other
Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer.
PMID 19661041·Clin Breast Cancer·2009
8-other
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
PMID 19384931·Am J Hematol·2009
8-other
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
PMID 19448681·Bone Marrow Transplant·2009
3-trial
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.
PMID 19361751·Biol Blood Marrow Transplant·2009
4-observational
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
PMID 19660722·Biol Blood Marrow Transplant·2009
8-other
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
PMID 19654407·Blood·2009
8-other
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
PMID 19561406·Curr Opin Oncol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1366541054
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile